[IgA脏病:一个新的治疗时代的开始]
Vanja Salvadè1, Daniel Teta1, Gabriella Guzzo1
1Service de néphrologie, Centre hospitalier du Valais romand, Hôpital de Sion, 1951 Sion.
Revue medicale suisse
|February 28, 2024
概括
初级IgA脏病,一种常见的脏疾病,在高达40%的病例中,可能会发展为功能衰竭. 最近的进展提供了新的治疗方法,改善了这种球状疾病的管理和患者的治疗结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
背景情况:
- 初级IgA脏病 (IgAN) 是一种常见的质细胞疾病,临床结果各不相同.
- 历史上被低估,Igan可以在20-30年内在40%的患者中导致末期病.
- 最近的研究已经阐明了Igan的病理生理学,改善了进展性形式的预后能力和积极的治疗策略.
研究的目的:
- 审查针对IgA病的已知治疗方法.
- 突出显示 IgAN 管理中显著有效性的新型治疗剂.
- 讨论针对异常IgA生产和免疫细胞通路的新兴治疗方法.
主要方法:
- 对IgA病的古典和当代治疗方式的审查.
- 对斯帕森坦和向释放布登酸的临床试验数据的分析.
- 探索补充剂,B细胞和血细胞抑制剂的临床前和临床研究.
主要成果:
- 斯帕森坦和向释放布登化物在治疗渐进性IgA脏病方面表现出显著的疗效.
- 针对异常IgA生产的新兴疗法,包括补充剂和B/血细胞抑制剂,显示出有前途.
- 对IgAN病理生理学的理解有所进步,使得更好的预测和治疗成为可能.
结论:
- 了解IGAN病理生理学的进步正在改变其管理.
- 新的治疗选择,如斯帕森坦和布登化物,为进展性疾病提供了更好的治疗结果.
- 针对IgA生产的向治疗预示着IgAN治疗的潜在新时代.
更多相关视频
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
429
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
429
01:11Renal Failure: Dose Adjustments
88
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
88